Cohance Lifesciences Limited — Spironolactone Exporter Profile
Indian Pharmaceutical Exporter · #8 for Spironolactone · $1.6M export value · DGFT Verified
Cohance Lifesciences Limited is the #8 Indian exporter of Spironolactone with $1.6M in export value and 32 verified shipments. Cohance Lifesciences Limited holds a 0.8% market share in Spironolactone exports across 2 countries. The company exports 4 pharmaceutical products worth $13.6M across 4 therapeutic categories.
Cohance Lifesciences Limited — Spironolactone Export Profile: Buyers & Destinations
Where Does Cohance Lifesciences Limited Export Spironolactone?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $843.9K | 30 | 92.7% |
| UNITED STATES OF AMERICA | $66.7K | 2 | 7.3% |
Cohance Lifesciences Limited exports Spironolactone to 2 countries. The largest destination is CANADA accounting for 92.7% of Cohance Lifesciences Limited's Spironolactone shipments. These destinations reflect Cohance Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Spironolactone from Cohance Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MINT PHARMACEUTICALS INC | CANADA | $738.6K | 27 |
| MINT PHARMACEUTICALS INC . | CANADA | $92.2K | 2 |
| MINT PHARMACEUTICALS INC,. | CANADA | $79.9K | 3 |
Cohance Lifesciences Limited supplies Spironolactone to 3 buyers globally. The largest buyer is MINT PHARMACEUTICALS INC (CANADA), followed by MINT PHARMACEUTICALS INC . (CANADA) and MINT PHARMACEUTICALS INC,. (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Spironolactone Export Value and How Much Does Cohance Lifesciences Limited Contribute?
India exported $67.2M worth of Spironolactone through 5,262 shipments from 259 suppliers to 112 countries, serving 471 buyers globally. Cohance Lifesciences Limited contributes $1.6M to this total, accounting for 0.8% of India's Spironolactone exports. Cohance Lifesciences Limited ships Spironolactone to 2 countries through 3 buyers.
What Is the Average Shipment Value for Cohance Lifesciences Limited's Spironolactone Exports?
Cohance Lifesciences Limited's average Spironolactone shipment value is $50.0K per consignment, based on 32 shipments totaling $1.6M. The largest destination is CANADA (92.7% of Cohance Lifesciences Limited's Spironolactone exports).
How Does Cohance Lifesciences Limited Compare to Other Indian Spironolactone Exporters?
Cohance Lifesciences Limited ranks #8 among 259 Indian Spironolactone exporters with a 0.8% market share. The top 3 exporters are AMNEAL PHARMACEUTICALS PRIVATE LIMITED ($18.6M), ZYDUS LIFESCIENCES LIMITED ($13.1M), INTAS PHARMACEUTICALS LIMITED ($12.2M). Cohance Lifesciences Limited processed 32 shipments to 2 destination countries.
What Spironolactone Formulations Does Cohance Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SPIRONOLACTONE TABLETS USP 25MG (500S-COUNT) | $133.4K | 4 |
| SPIRONOLACTONE TABLETS USP 25MG 8882 BOTTLES OF 500 S 4441000 TABS | $100.0K | 2 |
| SPIRONOLACTONE TABLETS USP 100MG 22014BOTTLES OF 100 S 2201400 TABS | $100.0K | 2 |
| SPIRONOLACTONE TABLETS USP 25MG 12201 BOTTLES OF 500 S 6100500 TABS | $100.0K | 2 |
| SPIRONOLACTONE TABLETS USP 25MG (500S-CO | $92.9K | 2 |
| SPIRONOLACTONE TABLETS USP 100MG (100S-COUNT) | $66.6K | 2 |
| SPIRONOLACTONE TABLETS USP 100MG (100S-C | $64.5K | 2 |
| SPIRONOLACTONE TABLETS USP 100MG ( 11064 | $50.0K | 1 |
| SPIRONOLACTONE TABLETS USP 25MG ( 5345 B | $42.2K | 1 |
| SPIRONOLACTONE TABLETS USP 25MG (500`S-COUNT) (5328 BOTTLES OF 500`S=2664000 TABS) | $39.8K | 1 |
Cohance Lifesciences Limited exports 17 distinct Spironolactone formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SPIRONOLACTONE TABLETS USP 25MG (500S-COUNT) with 4 shipments worth $133.4K.
Regulatory Requirements: Exporting Spironolactone to Key Markets
What Cohance Lifesciences Limited must comply with to export Spironolactone to its top destination countries
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Cohance Lifesciences Limited Compare to Nearest Spironolactone Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | CADILA HEALTHCARE LIMITED | $2.5M | 49 | 1 | $50.0K |
| 7 | PIRAMAL PHARMA LIMITED | $2.2M | 44 | 2 | $50.0K |
| 8 | COHANCE LIFESCIENCES LIMITED ★ | $1.6M | 32 | 2 | $50.0K |
| 11 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED | $730.6K | 32 | 1 | $22.8K |
| 12 | GRACURE PHARMACEUTICALS LIMITED | $584.7K | 16 | 1 | $36.5K |
Cohance Lifesciences Limited ranks #8 among 259 Indian Spironolactone exporters. Average shipment value of $50.0K compared to the market average of $259.6K. The closest competitors by value are CADILA HEALTHCARE LIMITED and PIRAMAL PHARMA LIMITED.
Which Indian Ports Ship Spironolactone Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 870 | 16.5% |
| DELHI AIR | 678 | 12.9% |
| SAHAR AIR | 633 | 12.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 594 | 11.3% |
| MUNDRA SEA | 443 | 8.4% |
| MUNDRA SEA (INMUN1) | 391 | 7.4% |
| Delhi Air | 164 | 3.1% |
| NHAVA SHEVA SEA (INNSA1) | 132 | 2.5% |
Geopolitical & Trade Policy Impact on Cohance Lifesciences Limited's Spironolactone Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Cohance Lifesciences. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and shipping costs. This situation necessitates strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost efficiency.
Conversely, the U.S.-China trade tensions have opened avenues for Indian exporters to capture market share previously dominated by Chinese manufacturers. Cohance's established presence and compliance with international standards position it favorably to meet the increased demand from U.S. importers seeking reliable alternatives.
The recent India-European Union Free Trade Agreement (FTA), concluded on January 27, 2026, eliminates tariffs on Indian pharmaceutical exports to the EU, including duties of up to 11% on pharmaceuticals. This development enhances Cohance's competitiveness in the European market, potentially boosting export volumes and revenues. (en.wikipedia.org)
Cohance Lifesciences Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. The USFDA's issuance of a warning letter to Cohance's Hyderabad facility highlights the critical importance of adhering to Good Manufacturing Practices (GMP). While the immediate financial impact may be minimal due to the facility's limited contribution to U.S. revenues, the long-term implications on reputation and market access are significant. Proactive remediation and transparent communication with regulatory bodies are essential to restore and maintain compliance.
Additionally, the European Union's Falsified Medicines Directive (FMD) imposes stringent requirements on pharmaceutical imports. Cohance must ensure robust serialization and traceability measures to comply with these regulations, thereby safeguarding its access to the lucrative EU market.
About Cohance Lifesciences Limited
Cohance Lifesciences Limited exports 4 products worth $13.6M. Beyond Spironolactone, top products include Isosorbide, Itraconazole, Tetracycline. View the complete Cohance Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Spironolactone — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Spironolactone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Cohance Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 32 individual customs records matching Cohance Lifesciences Limited exporting Spironolactone, covering 17 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 471+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Spironolactone Export Data from Cohance Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Cohance Lifesciences Limited's Spironolactone exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Cohance Lifesciences Limited
Full Company Profile →
4 products · $13.6M total trade · 4 categories
Spironolactone Stats
Company Overview
Top Products by Cohance Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Cohance Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Spironolactone. For current shipment-level data, contact TransData Nexus.